Jonathan Jian Wang serves as Executive at RESPONSE BIOMEDICAL CORP, where they oversee executive responsibilities. Since joining the company, Jonathan Jian Wang has executed 12 insider transactions totaling $500.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 25, 2025 involved receiving (via award) 971,173 shares valued at $0.
Jonathan Jian Wang currently holds 971,173 shares of RESPONSE BIOMEDICAL CORP (RBM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Jian Wang has been a net buyer of RBM stock. They have purchased $500.0K and sold $0 worth of shares.
Jonathan Jian Wang's most recent insider trade was on Jul 25, 2025, when they sold 971,173 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 29, 2016 | RBM | $0 | Other | 2,149,902 | $N/A | Discretionary |
| Nov 29, 2016 | RBM | $0 | Other | 34,291 | $N/A | Discretionary |
| Nov 29, 2016 | RBM | $0 | Other | 3,604,266 | $N/A | Discretionary |
| Nov 29, 2016 | RBM | $0 | Other | 71,396 | $N/A | Discretionary |
| Jun 16, 2016 | RBM | $311.5K | Purchase | 556,339 | $0.56 | Discretionary |
| Jun 16, 2016 | RBM | $185.5K | Purchase | 331,225 | $0.56 | Discretionary |
| Jun 16, 2016 | RBM | $3.0K | Purchase | 5,294 | $0.56 | Discretionary |
| Mar 24, 2016 | RBM | $0 | Award | 26,176 | $N/A | Discretionary |
| May 19, 2015 | RBM | $0 | Award | 7,291 | $N/A | Discretionary |
| Mar 19, 2015 | RBM | $0 | Award | 6,250 | $N/A | Discretionary |